The β-globin Replicator greatly enhances the potential of S/MAR based episomal vectors for gene transfer into human haematopoietic progenitor cells

被引:18
|
作者
Stavrou, Eleana F. [1 ]
Lazaris, Vassileios M. [1 ]
Giannakopoulos, Aristeidis [1 ]
Papapetrou, Eirini [1 ,4 ]
Spyridonidis, Alexandros [2 ]
Zoumbos, Nikolas C. [2 ]
Gkountis, Antonis [3 ]
Athanassiadou, Aglaia [1 ]
机构
[1] Univ Patras, Sch Med, Dept Gen Biol, GR-26110 Patras, Greece
[2] Univ Patras, Sch Med, Dept Internal Med, Haematol Unit, GR-26110 Patras, Greece
[3] George Papanicolaou Hosp, BMT Unit, Dept Haematol, Gene & Cell Therapy Ctr, Thessaloniki, Greece
[4] Icahn Sch Med Mt Sinai, Dept Oncol Sci, One Gustave L Levy Pl,Box 1044A, New York, NY 10029 USA
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
关键词
SCAFFOLD/MATRIX ATTACHMENT REGION; TRANSGENE EXPRESSION; MITOTIC STABILITY; REPOPULATING CELLS; LENTIVIRAL VECTOR; T-CELLS; TRANSCRIPTION; BINDING; ORIGIN; SITES;
D O I
10.1038/srep40673
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Specific human chromosomal elements enhance the performance of episomal gene-transfer vectors. S/MAR-based episomal vector pEPI-eGFP transfects CD34(+) haematopoietic cells, but only transiently. To address this issue we reinforced (1) transgene transcription by replacing the CMV promoter driving eGFP with the EF1/HTLV or SFFV promoters to produce vectors pEPI-EF1/HTLV and pEPI-SFFV, respectively; and (2) plasmid replication by inserting the replication-Initiation Region (IR) from the beta-globin locus into vector pEPI-SFFV to produce vector pEP-IR. All vectors supported stable transfections in K562 cells. Transfections of CD34(+) cells from peripheral blood of healthy donors reached 30% efficiency. Upon evaluation of CD34(+)/eGFP(+) cells in colony-forming cell (CFC) assays, vector pEP-IR showed superior performance after 14 days, by fluorescent microscopy: 100% eGFP(+)-colonies against 0% for pEPI-eGFP, 56.9% for pEPI-SFFV and 49.8% for pEPI-EF1/HTLV; 50% more plasmid copies per cell and 3-fold eGFP expression compared to the latter two constructs, by quantitative (q)PCR and RT-qPCR, respectively. Importantly, the establishment rate in CFC assays was 15% for pEP-IR against 5.5% for pEPI-SFFV and 5% for pEPI-EF1/HTLV. Vector pEP-IR shows extremely low delivery rate but supports eGFP expression in thalassaemic mouse haematopoietic progenitor cells. The IR is a novel human control element for improved episomal gene transfer into progenitor cells.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Pseudotyped recombinant adeno-associated virus vectors for clinically relevant gene transfer efficiency into primary human CD34+peripheral blood progenitor cells
    Sellner, Leopold
    Veldwijk, Marlon R.
    Stiefelhagen, Marius
    Kleinschmidt, Juergen A.
    Laufs, Stephanie
    Zeller, W. Jens
    Fruehauf, Stefan
    Wenz, Frederik
    HUMAN GENE THERAPY, 2008, 19 (10) : 1094 - 1094
  • [42] Stable marker gene transfer into human bone marrow stromal cells and their progenitors using novel herpesvirus saimiri-based vectors
    Frolova-Jones, EA
    Ensser, A
    Stevenson, AJ
    Kinsey, SE
    Meredith, DM
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (04): : 573 - 581
  • [43] Genetic labeling of human CD34-positive hematopoietic progenitor cells and mesenchymal stem cells by highly efficient mRNA-based gene transfer
    Greiner, J.
    Torzewski, J.
    Ponsearts, P.
    Rojewski, M.
    Kronawitter, D.
    Schrezenmeier, H.
    Hombach, V.
    Doehner, H.
    Schmitt, M.
    Wiesneth, M.
    Zimmermann, O.
    Wiehe, J. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 68 - 69
  • [44] Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors
    Chinnasamy, N
    Chinnasamy, D
    Toso, JF
    Lapointe, R
    Candotti, F
    Morgan, RA
    Hwu, P
    HUMAN GENE THERAPY, 2000, 11 (13) : 1901 - 1909
  • [45] Labeling of human CD34-positive hematopoietic progenitor and mesenchymal stem cells for human in vivo application by highly efficient mRNA-based gene transfer
    Wiehe, J. M. I.
    Ponsaerts, P.
    Rojewski, M.
    Homann, J. M.
    Greiner, J.
    Kronawitter, D.
    Hombach, V.
    Wiesneth, M.
    Torewski, J.
    CYTOTHERAPY, 2006, 8 : 16 - 16
  • [46] Isolation and characterization of cultured human dendritic cells: A potential target for adenoviral-based gene transfer of tumour peptides.
    Wan, Y
    Ross, C
    Walker, I
    Gauldie, J
    Foley, R
    BLOOD, 1997, 90 (10) : 4636 - 4636
  • [47] Lenti-viral based gene transfer vectors efficiently transduce human cord blood CD34+/CD38- cells.
    Kelly, PF
    Evans, JT
    Douglas, JL
    O'Neill, E
    Garcia, JV
    BLOOD, 1998, 92 (10) : 149A - 149A
  • [48] Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in clonogenic mouse hematopoietic progenitor cells
    Letourneau, S
    Greenbaum, M
    Cournoyer, D
    HUMAN GENE THERAPY, 1996, 7 (07) : 831 - 840
  • [49] Fibronectin fragment CH-296 inhibits apoptosis and enhances ex vivo gene transfer by murine retrovirus and human lentivirus vectors independent of viral tropism in nonhuman primate CD34+ cells
    Donahue, RE
    Sorrentino, BP
    Hawley, RG
    An, DS
    Chen, ISY
    Wersto, RP
    MOLECULAR THERAPY, 2001, 3 (03) : 359 - 367
  • [50] Gene transfer to repopulating human CD34+cells using amphotropic, GALV or RD114 pseudotyped HIV-1 based vectors from stable producer cells.
    Richter, J
    Johansson, M
    Relander, T
    Olsson, K
    Ikeda, Y
    Takeuchi, Y
    Collins, M
    BLOOD, 2004, 104 (11) : 579A - 579A